Zonampanel

From Food & Medicine Encyclopedia

Zonampanel is a chemical compound that is classified as a non-competitive antagonist of the AMPA receptor, a type of ionotropic glutamate receptor. It was developed by Yamanouchi Pharmaceutical Co., a Japanese pharmaceutical company, and has been studied for potential use in the treatment of epilepsy and Parkinson's disease.

History[edit]

Zonampanel was first synthesized by Yamanouchi Pharmaceutical Co. in the late 1990s. The compound was developed as part of a larger effort to create new treatments for neurological disorders. Early studies showed that Zonampanel could effectively block the AMPA receptor, suggesting potential use in conditions characterized by excessive glutamate activity.

Mechanism of Action[edit]

Zonampanel works by blocking the AMPA receptor, a type of ionotropic glutamate receptor. Glutamate is the primary excitatory neurotransmitter in the brain, and excessive activity of the glutamate system has been implicated in a number of neurological and psychiatric disorders. By blocking the AMPA receptor, Zonampanel can reduce glutamate activity and potentially alleviate symptoms of these disorders.

Clinical Trials[edit]

Zonampanel has been tested in several clinical trials for its potential use in treating epilepsy and Parkinson's disease. However, the results have been mixed. Some studies have shown promising results, while others have found no significant benefit. As of now, Zonampanel is not approved for use in any country.

Potential Uses[edit]

While Zonampanel is not currently approved for use, research continues into its potential applications. It may have potential as a treatment for epilepsy, Parkinson's disease, and other conditions characterized by excessive glutamate activity. However, more research is needed to confirm these potential uses and to fully understand the safety and efficacy of Zonampanel.

See Also[edit]

This article is a stub related to chemistry. You can help WikiMD by expanding it!


Stub icon

This neuroscience article is a stub. You can help Wikipedia by adding missing information.

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


  • Zonampanel
    Zonampanel
  • Zonampanel molecule spacefill
    Zonampanel molecule spacefill
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:

Advertise on WikiMD

WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Zonampanel&oldid=6305173"